Dear Members,
Ailsa is preparing for a presentation at this year’s British Society for Rheumatology conference about 'The Future of Patient Choice in Biologics'. The objectives of the symposium are as follows:
• Review the factors influencing treatment decisions in rheumatology, assessing their relative importance from the point of view of both health professionals and patients
• Examine more closely the role, needs and behaviours of patients in the management of their condition, taking into account impact of therapies on patients
• Explore the implications for future collaboration between patients and health professionals of the recent government White Paper on NHS reform
If you are someone who has a diagnosis of Rheumatoid Arthritis and are either about to start a biologic, are on a biologic or are switching to a different biologic, we would be grateful if you have a few moments to take the following survey
CLICK HERE TO TAKE SURVEY (only 8 questions) and help inform Ailsa’s presentation.
Many thanks!